Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia
Monday, December 5, 2016 - 13:31
in Health & Medicine
Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).